96945 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators; Fibroblast growth factors [FGF] acidic FGF [aFGF]
CAVIAR POLYPEPTIDES
#2Cell cultivation processes for preparing food products, products provided by said processes and a system for providing these processes
#3RECOMBINANT PRODUCTION OF GROWTH FACTORS IN ALGAE FOR CELL CULTURE APPLICATIONS
#4HUMAN FIBROBLAST GROWTH FACTOR 1 (FGF-1) MUTEINS, THEIR DIMERS AND USES
#5SYNTHETIC FOLDABLE PROTEINS GENERATED FROM PEPTIDE SEGMENTS OF FOLDING NUCLEI OF REFERENCE PROTEINS
#6RECOMBINANT MODIFIED FIBROBLAST GROWTH FACTORS AND THERAPEUTIC USES THEREOF
#7ENGINEERED FGF1 AND FGF2 COMPOSITIONS AND METHODS OF USE THEREOF
#8MODIFIED FIBROBLAST GROWTH FACTORS FOR THE TREATMENT OF OCULAR DISORDERS
#9Recombinant modified fibroblast growth factors and therapeutic uses thereof
#10FIBROBLAST GROWTH FACTOR (FGF) 1 WITH MUTATION IN THE HEPARIN BINDING DOMAIN AND METHODS OF USE TO REDUCE BLOOD GLUCOSE
#11Engineered FGF1 and FGF2 compositions and methods of use thereof
#12USE OF FIBROBLAST GROWTH FACTOR 1 (FGF1)-VAGUS NERVE TARGETING CHIMERIC PROTEINS TO TREAT HYPERGLYCEMIA
#13MUTATED FIBROBLAST GROWTH FACTOR (FGF) 1 AND METHODS OF USE
#14FIBROBLAST GROWTH FACTOR (FGF) 1 PROTEINS WITH GLUCOSE LOWERING ABILITY AND REDUCED MITOGENICITY
#15Dominant-negative FGF2 antagonists
#16FIBROBLAST GROWTH FACTOR MUTANTS HAVING IMPROVED FUNCTIONAL HALF-LIFE AND METHODS OF THEIR USE
#17Treatment of steroid-induced hyperglycemia with fibroblast growth factor (FGF) 1 analogs
#18MUTATED FIBROBLAST GROWTH FACTOR (FGF) 1 AND METHODS OF USE
#19Chimeric fibroblast growth factor 19 proteins and methods of use
#20Chimeric fibroblast growth factor 21 proteins and methods of use
#21Synthetic foldable proteins generated from peptide segments of folding nuclei of reference proteins
#22FIBROBLAST GROWTH FACTOR (FGF) 1 WITH MUTATION IN THE HEPARIN BINDING DOMAIN AND METHODS OF USE TO REDUCE BLOOD GLUCOSE
#23Chimeric fibroblast growth factor 23 proteins and methods of use
#24Engineered FGF compositions and methods of use thereof
#25Chimeric fibroblast growth factor 19 proteins and methods of use
#26Fibroblast growth factor mutants having improved functional half-life and methods of their use
#27Fibroblast growth factor mutants having improved functional half-life and methods of their use
#28Chimeric fibroblast growth factor 21 proteins and methods of use
#29Modified fibroblast growth factors for the treatment of ocular disorders
#30CHIMERIC FIBROBLAST GROWTH FACTOR (FGF) 2/FGF1 PEPTIDES AND METHODS OF USE
#31Chimeric fibroblast growth factor (FGF) 2/FGF1 peptides and methods of use
#32Fibroblast growth factor mutants having improved functional half-life and methods of their use
#33Mutated fibroblast growth factor (FGF) 1 and methods of use
#34Modified acidic fibroblast growth factors and composition thereof
#35FGF-2 variants and methods of use thereof
#36FGF-9 variants and methods of use thereof
#37Fibroblast growth factor mutants having improved functional half-life and methods of their use
#38Compositions and methods related to anti-FGF agents
#39Medicinal Compositions Containing Highly Functionalized Chimeric Protein
#40FGF-9 variants and methods for use thereof
#41Fibroblast growth factor mutants having improved functional half-life and methods of their use
#42Medicinal Composition Containing Highly Functionalized Chimeric Protein
#43Modified peptide of human acidic fibroblast growth factor
#44CIRCULAR DNA MOLECULE HAVING A CONDITIONAL ORIGIN OF REPLICATION, PROCESS FOR THEIR PREPARATION AND THEIR USE IN GENE THERAPY
#45FGF variants and methods for use thereof
#46Plasmid PXL3179 or NV1FGF
#47Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
#48METHOD OF PRODUCING BIOLOGICALLY ACTIVE HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AND ITS USE IN PROMOTING ANGIOGENESIS
#49Hecgf-1 Related Polymorphisms and Applications Thereof
#50Heparin-binding protein modified with heparan sulfate sugar chains, process for producing the same and pharmaceutical compositions containing the same
#51CIRCULAR DNA MOLECULE HAVING A CONDITIONAL ORIGIN OF REPLICATION, PROCESS FOR THEIR PREPARATION AND THEIR USE IN GENE THERAPY
#52Compositions and methods related to anti-FGF agents
#53Methods of obtaining neural stem cells
#54Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
#55FGF18 production in prokaryotic hosts
#56Targeted adenovirus vectors for delivery of heterologous genes
#57Recombinant fibroblast growth factor analogs
#58Structure-based design and synthesis of FGF inhibitors and FGF modulator compounds
#59FGF variants and methods for use thereof